Aeglea BioTherapeutics Shares Up ~15% Premarket; Hearing Evercore ISI Initiated Coverage With $37 Price Target, Called Stock 'One Of The Most Compelling Investment Opportunities In Small-Cap Biotech'

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!